144 related articles for article (PubMed ID: 11990460)
1. Repeated treatment with S. aureus superantigens expands the survival rate of Ehrlich ascites tumor bearing mice.
Mondal TK; Bhatta D; Biswas S; Pal P
Immunol Invest; 2002 Feb; 31(1):13-28. PubMed ID: 11990460
[TBL] [Abstract][Full Text] [Related]
2. Superantigen-induced apoptotic death of tumor cells is mediated by cytotoxic lymphocytes, cytokines, and nitric oxide.
Mondal TK; Bhatta D; Biswas S; Pal P
Biochem Biophys Res Commun; 2002 Feb; 290(4):1336-42. PubMed ID: 11812010
[TBL] [Abstract][Full Text] [Related]
3. Activation of human T cells with NK cell markers by staphylococcal enterotoxin A via IL-12 but not via IL-18.
Ami K; Ohkawa T; Koike Y; Sato K; Habu Y; Iwai T; Seki S; Hiraide H
Clin Exp Immunol; 2002 Jun; 128(3):453-9. PubMed ID: 12109440
[TBL] [Abstract][Full Text] [Related]
4. Intratumoral IL-18 gene transfer improves therapeutic efficacy of antibody-targeted superantigen in established murine melanoma.
Wang Q; Yu H; Ju DW; He L; Pan JP; Xia DJ; Zhang LH; Cao X
Gene Ther; 2001 Apr; 8(7):542-50. PubMed ID: 11319621
[TBL] [Abstract][Full Text] [Related]
5. Synergistic immunopotentiating effects induced by T-cell and B-cell superantigen in mice.
Mondal TK; Bhatta D; Ray PK; Pal P
Immunol Invest; 2001 Aug; 30(3):169-80. PubMed ID: 11570638
[TBL] [Abstract][Full Text] [Related]
6. Repeated treatment with antibody-targeted superantigens strongly inhibits tumor growth.
Rosendahl A; Kristensson K; Hansson J; Ohlsson L; Kalland T; Dohlsten M
Int J Cancer; 1998 Apr; 76(2):274-83. PubMed ID: 9537591
[TBL] [Abstract][Full Text] [Related]
7. Antibody-targeted superantigen therapy induces tumor-infiltrating lymphocytes, excessive cytokine production, and apoptosis in human colon carcinoma.
Litton MJ; Dohlsten M; Lando PA; Kalland T; Ohlsson L; Andersson J; Andersson U
Eur J Immunol; 1996 Jan; 26(1):1-9. PubMed ID: 8566049
[TBL] [Abstract][Full Text] [Related]
8. Adenovirus-mediated intratumoral lymphotactin gene transfer potentiates the antibody-targeted superantigen therapy of cancer.
Wang Q; Yu H; Zhang L; Ju D; Pan J; Xia D; Yao H; Zhang W; Wang J; Cao X
J Mol Med (Berl); 2002 Sep; 80(9):585-94. PubMed ID: 12226740
[TBL] [Abstract][Full Text] [Related]
9. A superantigen-antibody fusion protein for T-cell immunotherapy of human B-lineage malignancies.
Gidlöf C; Dohlsten M; Lando P; Kalland T; Sundström C; Tötterman TH
Blood; 1997 Mar; 89(6):2089-97. PubMed ID: 9058731
[TBL] [Abstract][Full Text] [Related]
10. Antibody-targeted superantigens are potent inducers of tumor-infiltrating T lymphocytes in vivo.
Dohlsten M; Hansson J; Ohlsson L; Litton M; Kalland T
Proc Natl Acad Sci U S A; 1995 Oct; 92(21):9791-5. PubMed ID: 7568219
[TBL] [Abstract][Full Text] [Related]
11. T cell- and perforin-dependent depletion of B cells in vivo by staphylococcal enterotoxin A.
Sundstedt A; Grundström S; Dohlsten M
Immunology; 1998 Sep; 95(1):76-82. PubMed ID: 9767460
[TBL] [Abstract][Full Text] [Related]
12. S. aureus superantigen protein A expands CD4(+)/CD8(+)/CD19(+)/CD34(+) cells in mice: a potential immunorestorer.
Ghosh AK; Sinha P; Das T; Sa G; Ray PK
Biochem Biophys Res Commun; 1999 Mar; 256(1):142-6. PubMed ID: 10066438
[TBL] [Abstract][Full Text] [Related]
13. Long-term survival and complete cures of B16 melanoma-carrying animals after therapy with tumor-targeted IL-2 and SEA.
Rosendahl A; Kristensson K; Carlsson M; Skartved NJ; Riesbeck K; Søgaard M; Dohlsten M
Int J Cancer; 1999 Mar; 81(1):156-63. PubMed ID: 10077167
[TBL] [Abstract][Full Text] [Related]
14. Enhanced and prolonged efficacy of superantigen-induced cytotoxic T lymphocyte activity by interleukin-2 in vivo.
Belfrage H; Dohlsten M; Hedlund G; Kalland T
Cancer Immunol Immunother; 1995 Aug; 41(2):87-94. PubMed ID: 7656274
[TBL] [Abstract][Full Text] [Related]
15. Staphylococcal enterotoxin B primes cytokine secretion and lytic activity in response to native bacterial antigens.
Mason KM; Dryden TD; Bigley NJ; Fink PS
Infect Immun; 1998 Nov; 66(11):5082-8. PubMed ID: 9784507
[TBL] [Abstract][Full Text] [Related]
16. Immunopharmacology of the superantigen staphylococcal enterotoxin A in T-cell receptor V beta 3 transgenic mice.
Dohlsten M; Björklund M; Sundstedt A; Hedlund G; Samson D; Kalland T
Immunology; 1993 Aug; 79(4):520-7. PubMed ID: 7691731
[TBL] [Abstract][Full Text] [Related]
17. Development of a novel in vitro co-culture system for studying host response to native bacterial antigens.
Mason KM; Bigley NJ; Fink PS
J Immunol Methods; 1998 Feb; 211(1-2):147-58. PubMed ID: 9617839
[TBL] [Abstract][Full Text] [Related]
18. The distinct role of CD4+ and CD8+ T-cells during the anti-tumour effects of targeted superantigens.
Litton MJ; Dohlsten M; Rosendahl A; Ohlsson L; Søgaard M; Andersson J; Andersson U
Br J Cancer; 1999 Sep; 81(2):359-66. PubMed ID: 10496366
[TBL] [Abstract][Full Text] [Related]
19. Immune response during tumor therapy with antibody-superantigen fusion proteins.
Rosendahl A; Hansson J; Sundstedt A; Kalland T; Dohlsten M
Int J Cancer; 1996 Sep; 68(1):109-13. PubMed ID: 8895549
[TBL] [Abstract][Full Text] [Related]
20. Superantigens anergize cytokine production but not cytotoxicity in vivo.
Sundstedt A; Dohlsten M; Hedlund G; Höidén I; Björklund M; Kalland T
Immunology; 1994 May; 82(1):117-25. PubMed ID: 7913912
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
